Avitech Lifesciences Inc. Launches E-Commerce Site to Market Avitol


DENVER, Sept. 28, 2006 (PRIMEZONE) -- Avitech Lifesciences Inc. (Other OTC:AVLF) announced that the Company has launched its first e-commerce site, www.avi-essence.com, to market Avitol. Avitol is a homeopathic product formulated to aid against avian flu and some of the most virulent strains of influenza.

The Company has directed its focus on launching this site immediately after learning of the alarming reports of a potential flu pandemic.

The e-commerce site www.avi-essence.com will make Avitol available for purchase in all countries internationally except for the U.S. and Canada.

Avitol can be purchased directly from the site with several purchase options. The site also provides customers with product knowledge and insightful links to reports on the benefits of Avitol and updates on avian flu worldwide.

Avitech Lifesciences Inc. is currently preparing a second e-commerce site to market the full line of homeopathic products the Company now has available. These products will be marketed under the name Avi-Essence and should be available for purchase at that e-commerce site within a month.

Avitech Lifesciences Inc. has been invited to participate in the 3rd Bird Flu Summit in Geneva, Switzerland. We consider it an honor to be included on the invitation list with such esteemed colleagues. This is the 3rd summit on Bird Flu in the last 18 months!

Avitech Lifesciences Inc. is currently seeking long-term distributorships for Avitol. Please submit all inquiries to www.avitechls.com

For more info visit our e-commerce website at www.avi-essence.com

About Avitech Lifesciences Inc.

Avitech Lifesciences Inc. is a firm focused on health and life sciences industry. Avitech helps entrepreneurs accelerate their business development by investing early in the company's development and taking an active role in its day-to-day operations by acting as collaborative partners with the companies we bring on board. Although Avitech Lifesciences Inc.'s primary mandate is the health and life sciences sector, the company's mandate will allow it to look at all investments to increase shareholder value

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.


            

Tags


Contact Data